Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-23T20:42:23.293Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalence of Multiple Sclerosis in Canada: A Systematic Review

Published online by Cambridge University Press:  02 December 2014

Alexandre Y. Poppe ,
Christina Wolfson  and
Bin Zhu
Alexandre Y. Poppe*
Affiliation:
Department of Clinical Neurosciences, Foothills Medical Centre, Calgary, Alberta, Canada
Christina Wolfson
Affiliation:
Department of Epidemiology & Biostatistics, Department of Medicine, McGill University, Allan memorial Institute, Montreal, Quebec
Bin Zhu
Affiliation:
Department of Epidemiology & Biostatistics, Department of Medicine, McGill University, Allan memorial Institute, Montreal, Quebec
*
Department of Clinical Neurosciences, Foothills Medical Centre, 1403 29th Street, Calgary, Alberta, T2N 2T9, Canada.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Studies of the prevalence of multiple sclerosis (MS) in Canada have generally been isolated to specific regions. Given the importance of multiple sclerosis as a cause of disability in adults, a comprehensive review of Canadian MS prevalence examining current data, interregional variation, deficiencies in knowledge and frontiers for research is timely.

Methods:

A systematic review of all studies addressing the prevalence of MS in Canada or regions within Canada, published in English or French since 1985, was conducted. Studies were identified using MEDLINE, EMBASE and bibliographic review. Ten studies were evaluated for methodological rigour and a test of heterogeneity across studies was performed and a measure of consistency (I2) estimated.

Results:

Studies were generally of high quality. Nine were restricted to regions within Canada and one provided an estimated national prevalence based on self-reported cases. All reported a high prevalence (>50 per 100 000). Latitude and longitude gradients were not striking while assessment of heterogeneity confirmed that regional differences were unlikely to be the result of sampling variability.

Conclusions:

This review confirms Canada as a country of very high MS prevalence and it is the first study to demonstrate that variation in regional estimates represents true differences in prevalence within Canada. Avenues for future MS prevalence research, including adoption of a national MS registry, are proposed.

Résumé:

RÉSUMÉ:Contexte:

Les études de prévalence de la sclérose en plaques (SEP) au Canada ont généralement porté sur des régions spécifiques du pays. Étant donné l'importance de la SEP comme cause d'invalidité chez les adultes, il est opportun de réviser la prévalence de la SEP au Canada en examinant les données actuelles, la variation interrégionale, les lacunes et les avenues de recherche.

Méthodes:

Nous avons révisé systématiquement toutes les études portant sur la prévalence globale ou régionale de la SEP au Canada, publiées en anglais ou en français depuis 1985. Nous avons utilisé MEDLINE, EMBASE et une revue bibliographique pour identifier les études. Nous avons évalué la rigueur méthodologique de dix études, ainsi que l'hétérogénéité entre les études et estimé la consistance interne des études.

Résultats:

Les études étaient généralement de bonne qualité. Neuf des études étaient des études régionales et une estimait la prévalence nationale à partir de cas autorapportés. Toutes ces études rapportaient une prévalence élevée (> 50 par 100 000). Un gradient de latitude ou de longitude n'était pas évident et l'évaluation de l'hétérogénéité a confirmé que des différences régionales n'étaient vraisemblablement pas le résultat de la variabilité de l'échantillonnage.

Conclusions:

Cette étude confirme que la prévalence de la SEP est très élevée au Canada. C'est la première étude à démontrer que la variation entre les estimations régionales représente des différences réelles dans la prévalence entre différentes régions du Canada. Nous proposons des avenues de recherche pour les études futures sur la prévalence de la SEP, dont la constitution d'un registre national de la SEP.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 35 , Issue 5 , November 2008 , pp. 593 - 601
Copyright
Copyright © The Canadian Journal of Neurological 2008

References

1. Poser, CM. The epidemiology of multiple sclerosis: a general overview. Ann Neurol. 1994 Dec;36 Suppl 2:S180–93.Google Scholar
2. Poser, CM. The diagnosis and management of multiple sclerosis. Acta Neurol Scand. 2005 Sep;112(3):199–201.CrossRefGoogle ScholarPubMed
3. Rosati, G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001 Apr;22(2):117–39.Google Scholar
4. Hader, WJ, Elliot, M, Ebers, GC. Epidemiology of multiple sclerosis in London and Middlesex County, Ontario, Canada. Neurology. 1988 Apr;38(4):617–21.CrossRefGoogle ScholarPubMed
5. Sloka, JS, Pryse-Phillips, WE, Stefanelli, M. Incidence and prevalence of multiple sclerosis in Newfoundland and Labrador. Can J Neurol Sci. 2005 Feb;32(1):37–42.Google Scholar
6. Pryse-Phillips, WE. The incidence and prevalence of multiple sclerosis in Newfoundland and Labrador, 1960-1984. Ann Neurol. 1986 Sep;20(3):323–8.Google Scholar
7. Hader, W. The incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan: a reappraisal. Neuroepidemiology. 1999;18:327–32.Google Scholar
8. Bhan, V, Brown, MG, Fisk, JD, Sketris, I, Stadnyk, K, MacKinnon-Cameron, D, Li, N. Incidence and prevalence of Multiple Sclerosis in Nova Scotia. American Academy of Neurology Annual Meeting, miami, Florida, April 14, 2005. Neurology. 2005; 64 Suppl 1: A320.Google Scholar
9. Warren, S, Warren, KG. Prevalence of multiple sclerosis in Barrhead County, Alberta, Canada. Can J Neurol Sci. 1992 Feb;19(1):72–5.Google Scholar
10. Sweeney, VP, Sadovnick, AD, Brandejs, V. Prevalence of multiple sclerosis in British Columbia. Can J Neurol Sci. 1986 Feb;13(1):47–51.Google Scholar
11. Klein, GM, Rose, MS, Seland, TP. A prevalence study of multiple sclerosis in the Crowsnest Pass region of southern Alberta. Can J Neurol Sci. 1994 Aug;21(3):262–5.Google Scholar
12. Warren, S, Warren, KG. Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada. Neurology. 1993 Sep;43(9):1760–3.Google Scholar
13. Beck, CA, Metz, LM, Svenson, LW, Patten, SB. Regional variation of multiple sclerosis prevalence in Canada. Mult Scler. 2005 Oct;11(5):516–9.Google Scholar
14. Svenson, LW, Woodhead, SE, Platt, GH. Regional variations in the prevalence rates of multiple sclerosis in the province of Alberta, Canada. Neuroepidemiology. 1994;13(1–2):8–13.Google Scholar
15. Hader, WJ LI. Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan. Neurology. 2007;69:1224–9.Google Scholar
16. 2006 Census. Statistics Canada; 2007.Google Scholar
17. Hader, W, Feasby, T, Rice, GPA, Ebers, G. Multiple sclerosis in Canadian native peoples. Neurology. 1985;35 Suppl 1:300.Google Scholar
18. Mirsattari, SM, Johnston, JB, McKenna, R, Del Bigio, MR, Orr, P, Ross, RT, et al. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology. 2001 Feb 13;56(3):317–23.Google Scholar
19. Warren, S, Svenson, LW, Warren, KG, Metz, LM, Patten, SB, Schopflocher, DP. Incidence of Multiple Sclerosis amound First Nation People in Alberta, Canada. Society for Epidemiologic Research, Toronto, Ontario, June 2005.Google Scholar
20. Warren, S SL, Warren, KG, Metz, LM, Patten, SB, Schopflocher, DP. Prevalence of multiple sclerosis in First Nations people of Alberta. Can J Neurol Sci. 2007;34(2):175–80.Google Scholar
21. Stroup, DF, Berlin, JA, Morton, SC, Olkin, I, Williamson, GD, Rennie, D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of observational studies in epidemiology (MOOSE) group. JAMA. 2000 Apr 19;283(15):2008–12.CrossRefGoogle ScholarPubMed
22. Lemeshow, AR, Blum, RE, Berlin, JA, Stoto, MA, Colditz, GA. Searching one or two databases was insufficient for meta-analysis of observational studies. J Clin Epidemiol. 2005 Sep;58(9):867–73.Google Scholar
23. Westlund, KB, Kurland, LT. Studies on multiple sclerosis in Winnipeg, Manitoba, and New Orleans, Louisiana. I. Prevalence; comparison between the patient groups in Winnipeg and New Orleans. Am J Hyg. 1953 May;57(3):380–96.Google Scholar
24. White, DN, Wheelan, L. Disseminated sclerosis; a survey of patients in the Kingston, Ontario, area. Neurology. 1959 Apr;9(4):256–72.Google Scholar
25. Alter, M, Talbert, OR, Allison, RS, Kurland, LT. The geographic distribution of multiple sclerosis. A comparative study in Charleston County, South Carolina and Halifax County, Nova Scotia. I. Prevalence in Charleston County, South Carolina. J S C Med Assoc. 1960 Jun;56:209–13.Google Scholar
26. Stazio, A, Kurland, LT, Bell, LG, Saunders, MG, Rogot, E. Multiple sclerosis in Winnipeg, Manitoba: methodological considerations of epidemiologic survey. ten year follow-up of a community wide study, and population re-survey. J Chronic Dis. 1964 May;17:415–38.Google Scholar
27. Bennett, L, Hamilton, R, Neutel, CI, Pearson, JC, Talbot, B. Survey of persons with multiple sclerosis in Ottawa, 1974-75. Can J Public Health. 1977 Mar-Apr;68(2):141–7.Google Scholar
28. Hader, WJ. Prevalence of multiple sclerosis in Saskatoon. Can Med Assoc J. 1982 Aug 15;127(4):295–7.Google Scholar
29. Dyment, DA, Willer, CJ, Scott, B, Armstrong, H, Ligers, A, Hillert, J, Paty, DW, et al. Genetic susceptibility to MS: a second stage analysis in Canadian MS families. Neurogenetics. 2001;3(3):145–51.Google Scholar
30. Willer, CJ, Dyment, DA, Risch, NJ, Sadovnick, AD, Ebers, GC., Canadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A. 2003;100(22):12877–82.Google Scholar
31. Higgins, JP, Thompson, SG, Deeks, JJ, Altman, DG. Measuring inconsistency in meta-analyses. BMJ. 2003 Sep 6;327(7414):557–60.Google Scholar
32. Hatala, R, Keitz, S, Wyer, P, Guyatt, G. Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results. CMAJ. 2005 Mar 1;172(5):661–5.CrossRefGoogle ScholarPubMed
33. Cowen, JB, Sjostrom, BF, Doughty, AS, Schiffer, RB. Case-finding for MS prevalence studies in small communities requires a community-based approach. Neuroepidemiology. 2007;28:246–52.Google Scholar
34. Fangerau, T, Schimrigk, S, Haupts, M, Kaeder, M, Ahle, G, Brune, N, Klinkenberg, K, et al. Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria. Acta Neurol Scand. 2004;109(6):385–89.Google Scholar
35. Polman, CH, Reingold, SC, Edan, G, Filippi, M, Hartung, HP, Kappos, L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005 Dec;58(6):840–6.Google Scholar
36. McDonald, WI, Compston, A, Edan, G, Goodkin, D, Hartung, HP, Lublin, FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 Jul;50(1):121–7.Google Scholar
37. Zivadinov, R, Iona, L, Monti-Bragadin, L, Bosco, A, Jurjevic, A, Taus, C, et al. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology. 2003 Jan-Feb;22(1):65–74.CrossRefGoogle ScholarPubMed
38. Hader, WJ, Irvine, DG, Schiefer, HB. A cluster-focus of multiple sclerosis at Henribourg, Saskatchewan. Can J Neurol Sci. 1990 Nov;17(4):391–4.Google Scholar
39. Orton, SM, Herrera, BM, Yee, IM, Valdar, W, Ramagopalan, SV, Sadovnick, AD, Ebers, GC. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2007;5:932–6.Google Scholar
40. Sadovnick, AD, Risch, NJ, Ebers, GC. Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Can J Neurol Sci. 1998;25:216–21.Google Scholar
41. Warren, S, Svenson, L, Woodhead, S, Warren, KG. Parental ancestry and risk of multiple sclerosis in Alberta, Canada. Neuroepidemiology. 1996 Jan-Feb;15(1):1–9.Google Scholar
42. Hostetler, J. The Hutterite Society. Baltimore: Johns Hopkins University; 1974.Google Scholar
43. Compston, A. Genetic susceptibility to multiple sclerosis. In: Compston, A, Ebers, G, Lassman, H, McDonald, I, Matthews, B, Werkerle, H, editors. McAlpines multiple sclerosis. Edinburgh: Churchill-Livingston; 1998. p. 101–42.Google Scholar
44. Pugliatti, M, Rosati, G, Carton, H, Riise, T, Drulovic, J, Vecsei, L, Milanov, I. The epidemiology of multiple sclerosis in Europe. Eur J Neurol. 2006;13:700–22.Google Scholar
45. Vukusic, S, Van Bockstael, V, Gosselin, S, Confavreux, C. Regional variations in the prevalence of multiple sclerosis in French farmers. J Neurol Neurosurg Psychiatry. 2007;78:707–9.Google Scholar
46. Coo, H, Aronson, KJ. A systematic review of several potential nongenetic risk factors for multiple sclerosis. Neuroepidemiology. 2004;23:1–12.Google Scholar
47. Myhr, KM, Grytten, N, Aarseth, JH, Nyland, H. The Norwegian Multiple Sclerosis National Competence Centre and National Multiple Sclerosis registry - a resource for clinical practice and research. Acta Neurol Scan. 2006;183:Suppl. 37–40.Google Scholar